Former ProNova executive bringing 25+ years of product and complex system engineering experience to commercialize and scale ScanTech’s innovative Electronic Cold-Pasteurization™ (ECP™) System
(Atlanta, GA) | July 20, 2020 – ScanTech Sciences’ announced today that Jeff Pelletier will serve as Chief Technology Officer/SVP of Engineering, reporting to Chief Executive Officer, Dwayne House. In this role, Pelletier will be responsible for leading the Company’s technology strategy and development including overseeing R&D innovations and all product and system engineering of its pioneering Electronic Cold Pasteurization™ (ECP™) food treatment systems.
Jeff brings over 25 years of experience to ScanTech Sciences from various leadership positions in engineering and technology sectors where he delivered numerous complex, software-controlled electromechanical devices from concept through commercialization. Prior to joining ScanTech, Pelletier served as Vice President of Research & Development for ProNova Solutions, a best-in-class proton therapy system for cancer treatment. In this position, Pelletier was responsible for the design, development and launch of a next-generation superconducting proton therapy system from concept to commercial launch, under aggressive timelines and budget constraints.
In addition to his proton therapy experiences, Pelletier previously held leadership positions at GE Healthcare and Hospira, where he held various senior roles responsible for program management, product development and engineering for market-leading medical devices and systems including infusion pumps, diagnostic imaging systems, and healthcare IT software systems.
“Innovation and best-in-class solutions for our customers are cornerstones for the success of our company. As we prepare our ECP™ system for commercial scale and the launch of our first facility, we are excited to bring on a leader with a proven track record of developing and commercially launching complex systems” said House. “Jeff is a proven innovator. He displays remarkable technical expertise, along with leadership skills to lead ScanTech beyond our first facility towards a truly scaled network of facilities, partnerships and tailored customer solutions – resulting in the potential to transform and create a safer global food supply chain.”
“I’m excited for the opportunity to deliver technology solutions that will make a difference in our food supply,” said Pelletier. “We are building a better future by addressing the problems that face our customers today and reimagining the way we treat food across the supply chain. I look forward to the launch of our Rio Grande Valley ECP™ Center and future facilities to come.”
ScanTech Sciences’ Co-founder & Chairman, Dolan Falconer said “Jeff brings ScanTech a wealth of real-world experience scaling advanced technologies from developmental projects to sustainable commercial business ventures. We are excited to have Jeff join our diverse executive team.”
Pelletier, who will be based in Atlanta, holds a Bachelor’s and Master’s degree in Electrical Engineering with a focus on electronics and software development, and a Master of Business Administration from the Kellogg School of Management, Northwestern University.
About ScanTech Sciences, Inc.
As the only designer, manufacturer, and operator of Electronic Cold-Pasteurization™ (ECP™) systems built exclusively for food treatment, ScanTech Sciences is setting a new standard in produce sterilization. Dedicated to replacing dangerous chemicals and outdated phytosanitary treatment methods, ScanTech Sciences helps distributors, retailers, and food processors to improve quality and food safety across the supply chain. With our patented ECP™ treatment combined with comprehensive logistics and information, we extend produce shelf-life, enhance visibility and reduce compliance risk and costs. For more information, visit www.scantechsciences.com
Interested in working for ScanTech Sciences, Inc.? Please visit www.scantechsciences.com/careers for the latest job postings.
Please contact firstname.lastname@example.org for further press inquiries.